Skip to main content
Back
Watch Compare

P3 Health Partners Inc.

Data quality: 100%
Also listed as PIIIW Nasdaq
PIII
Nasdaq Services Health Services
$2.64
▼ $0.11 (-3.85%)
Mkt Cap: 537.14 M
Price
$2.64
Mkt Cap
537.14 M
Day Range
$2.62 — $2.77
52-Week Range
$1.52 — $11.30
Volume
5,451
Open $2.77
50D / 200D Avg
$2.47
6.94% above
50D / 200D Avg
$5.68
53.43% below

Quick Summary

Key Takeaways

Negative free cash flow of -122.87 M
Capital efficient — spends only 0.01% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)18.48%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-1016.92%
Below sector avg (-1.53%)
ROIC-82.75%
Net Margin-9.07%
Op. Margin-17.64%

Safety

Debt / Equity
N/A
Current Ratio0.32
Interest Coverage-5.51

Valuation

PE (TTM)
-4.10
Below sector avg (-0.01)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (20 peers)
Metric Stock Sector Median
P/E -4.1 0.0
P/B — 3.1
ROE % -1016.9 -1.5
Net Margin % -9.1 -0.3
Rev Growth 5Y % — 19.1
D/E — 1.0

All Fundamental Metrics
Growth
Revenue Growth (1Y) 18.48% Revenue Growth (3Y) 405.31%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.44 B Net Income (TTM) -131.05 M
ROE -1016.92% ROA -18.52%
Gross Margin N/A Operating Margin -17.64%
Net Margin -9.07% Free Cash Flow (TTM) -122.87 M
ROIC -82.75% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.32
Interest Coverage -5.51 Asset Turnover 2.04
Working Capital -288.32 M Tangible Book Value -531.60 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.10 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.37
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -22.87%
Market Cap 537.14 M Enterprise Value 752.34 M
Per Share
EPS (Diluted TTM) -22.62 Revenue / Share 7.11
FCF / Share -0.60 OCF / Share -0.60
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.01% FCF Conversion 93.76%
SBC-Adj. FCF -129.31 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2021 FY2022
Revenue 1.50 B 1.27 B 58.76 M 1.05 B
Net Income -135.85 M -57.77 M -10.08 M -270.13 M
EPS (Diluted) -1.08 -0.63 -0.24 -6.50
Gross Profit — — — —
Operating Income -320.66 M -167.93 M -58.89 M -1.56 B
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A 86.06 M 86.68 M 187,558.0 87.29 M
Interest Expense -22.17 M -15.99 M -1.32 M -11.40 M
Income Tax 4.39 M 2.70 M 0.0 1.86 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2021 FY2022
Total Assets 783.42 M 860.97 M 2.36 B 876.57 M
Total Liabilities 633.89 M 427.31 M 299.94 M 353.91 M
Shareholders' Equity 75.94 M 142.13 M 273.55 M 5.85 M
Total Debt 89.82 M 108.32 M 83.62 M 98.00 M
Cash & Equivalents 38.82 M 36.32 M 140.48 M 17.54 M
Current Assets 184.14 M 166.02 M 199.86 M 100.69 M
Current Liabilities 496.42 M 299.37 M 198.77 M 241.66 M